Does PRAVASTATIN Cause Hepatic cytolysis? 49 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 49 reports of Hepatic cytolysis have been filed in association with PRAVASTATIN (Pravastatin Sodium). This represents 0.6% of all adverse event reports for PRAVASTATIN.
49
Reports of Hepatic cytolysis with PRAVASTATIN
0.6%
of all PRAVASTATIN reports
3
Deaths
23
Hospitalizations
How Dangerous Is Hepatic cytolysis From PRAVASTATIN?
Of the 49 reports, 3 (6.1%) resulted in death, 23 (46.9%) required hospitalization, and 3 (6.1%) were considered life-threatening.
Is Hepatic cytolysis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for PRAVASTATIN. However, 49 reports have been filed with the FAERS database.
What Other Side Effects Does PRAVASTATIN Cause?
Myalgia (1,290)
Arthralgia (570)
Dyspnoea (514)
Fatigue (500)
Drug hypersensitivity (493)
Diarrhoea (478)
Headache (448)
Pruritus (432)
Nausea (420)
Dizziness (413)
What Other Drugs Cause Hepatic cytolysis?
ACETAMINOPHEN (1,469)
ATORVASTATIN (681)
PEMBROLIZUMAB (601)
CARBOPLATIN (577)
METHOTREXATE (468)
SULFAMETHOXAZOLE\TRIMETHOPRIM (356)
PACLITAXEL (324)
ENOXAPARIN (307)
AMOXICILLIN (273)
VALACYCLOVIR (261)
Which PRAVASTATIN Alternatives Have Lower Hepatic cytolysis Risk?
PRAVASTATIN vs PRAVASTATIN\PRAVASTATIN
PRAVASTATIN vs PRAZAXA
PRAVASTATIN vs PRAZEPAM
PRAVASTATIN vs PRAZIQUANTEL
PRAVASTATIN vs PRAZOSIN